| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | EGF | 1.55e-05 | 126 | 79 | 6 | PF00008 | |
| Domain | EGF_1 | 1.02e-04 | 255 | 79 | 7 | PS00022 | |
| Domain | EGF-like_CS | 1.18e-04 | 261 | 79 | 7 | IPR013032 | |
| Domain | EGF_2 | 1.30e-04 | 265 | 79 | 7 | PS01186 | |
| Domain | TAAR_fam | 3.66e-04 | 7 | 79 | 2 | IPR009132 | |
| Domain | EGF_3 | 4.81e-04 | 235 | 79 | 6 | PS50026 | |
| Domain | Man6P_isomerase_rcpt-bd_dom | 4.87e-04 | 8 | 79 | 2 | IPR009011 | |
| Domain | EGF-like_dom | 6.52e-04 | 249 | 79 | 6 | IPR000742 | |
| Domain | APOBEC_N | 1.13e-03 | 12 | 79 | 2 | PF08210 | |
| Domain | APOBEC_N | 1.13e-03 | 12 | 79 | 2 | IPR013158 | |
| Domain | Peptidase_M1 | 1.34e-03 | 13 | 79 | 2 | PF01433 | |
| Domain | Peptidase_M1_N | 1.34e-03 | 13 | 79 | 2 | IPR014782 | |
| Domain | Sushi | 1.39e-03 | 52 | 79 | 3 | PF00084 | |
| Domain | CCP | 1.55e-03 | 54 | 79 | 3 | SM00032 | |
| Domain | APOBEC/CMP_deaminase_Zn-bd | 1.56e-03 | 14 | 79 | 2 | IPR016192 | |
| Domain | SUSHI | 1.72e-03 | 56 | 79 | 3 | PS50923 | |
| Domain | EGF_CA | 1.78e-03 | 122 | 79 | 4 | SM00179 | |
| Domain | Sushi_SCR_CCP_dom | 1.81e-03 | 57 | 79 | 3 | IPR000436 | |
| Domain | EGF-like_Ca-bd_dom | 1.89e-03 | 124 | 79 | 4 | IPR001881 | |
| Domain | TLC | 2.04e-03 | 16 | 79 | 2 | PS50922 | |
| Domain | TLC | 2.04e-03 | 16 | 79 | 2 | SM00724 | |
| Domain | TRAM_LAG1_CLN8 | 2.04e-03 | 16 | 79 | 2 | PF03798 | |
| Domain | TLC-dom | 2.04e-03 | 16 | 79 | 2 | IPR006634 | |
| Domain | Cytidine_deaminase-like | 2.31e-03 | 17 | 79 | 2 | IPR016193 | |
| Domain | CYT_DCMP_DEAMINASES_1 | 2.31e-03 | 17 | 79 | 2 | PS00903 | |
| Domain | CMP_dCMP_Zn-bd | 2.31e-03 | 17 | 79 | 2 | IPR002125 | |
| Domain | EGF | 3.20e-03 | 235 | 79 | 5 | SM00181 | |
| Domain | USP_1 | 3.25e-03 | 70 | 79 | 3 | PS00972 | |
| Domain | USP_2 | 3.39e-03 | 71 | 79 | 3 | PS00973 | |
| Domain | USP_3 | 3.52e-03 | 72 | 79 | 3 | PS50235 | |
| Domain | USP_dom | 3.52e-03 | 72 | 79 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 3.52e-03 | 72 | 79 | 3 | IPR001394 | |
| Domain | RHODANESE_3 | 4.22e-03 | 23 | 79 | 2 | PS50206 | |
| Domain | Growth_fac_rcpt_ | 4.33e-03 | 156 | 79 | 4 | IPR009030 | |
| Domain | Rhodanese-like_dom | 4.59e-03 | 24 | 79 | 2 | IPR001763 | |
| Domain | Rhodanese | 4.59e-03 | 24 | 79 | 2 | PF00581 | |
| Domain | - | 4.59e-03 | 24 | 79 | 2 | 3.40.250.10 | |
| Domain | K_chnl_volt-dep_Kv | 5.79e-03 | 27 | 79 | 2 | IPR003968 | |
| Domain | hEGF | 6.22e-03 | 28 | 79 | 2 | PF12661 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 21664424 | ||
| Pubmed | Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging. | 1.64e-05 | 3 | 82 | 2 | 32641479 | |
| Pubmed | APOBEC3 deletion increases the risk of breast cancer: a meta-analysis. | 1.64e-05 | 3 | 82 | 2 | 27602762 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 22691411 | ||
| Pubmed | Studies on the restriction of murine leukemia viruses by mouse APOBEC3. | 1.64e-05 | 3 | 82 | 2 | 22666481 | |
| Pubmed | APOBEC3 deletion polymorphism is associated with epithelial ovarian cancer risk among Chinese women. | 1.64e-05 | 3 | 82 | 2 | 24577894 | |
| Pubmed | APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism. | 1.64e-05 | 3 | 82 | 2 | 16648136 | |
| Pubmed | Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice. | 1.64e-05 | 3 | 82 | 2 | 23533681 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 1541833 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 27356895 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 23315078 | ||
| Pubmed | Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response. | 1.64e-05 | 3 | 82 | 2 | 25589647 | |
| Pubmed | Regulation of dendritic cell differentiation in bone marrow during emergency myelopoiesis. | 1.64e-05 | 3 | 82 | 2 | 23833236 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 23671100 | ||
| Pubmed | Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions. | 1.64e-05 | 3 | 82 | 2 | 31518043 | |
| Pubmed | APOBEC3 signature mutations in chronic lymphocytic leukemia. | 1.64e-05 | 3 | 82 | 2 | 24840555 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 9765497 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 24453360 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 26384307 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 23449789 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 21228213 | ||
| Pubmed | APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. | 1.64e-05 | 3 | 82 | 2 | 18434399 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 14701940 | ||
| Pubmed | Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. | 1.64e-05 | 3 | 82 | 2 | 19153238 | |
| Pubmed | Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. | 1.64e-05 | 3 | 82 | 2 | 18772436 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 24478388 | ||
| Pubmed | Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo. | 1.64e-05 | 3 | 82 | 2 | 18786991 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 286744 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 24725948 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 20702647 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 20980520 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 284359 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 20617165 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 31801862 | ||
| Pubmed | Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain. | 1.64e-05 | 3 | 82 | 2 | 39208378 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 31943071 | ||
| Pubmed | Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo. | 1.64e-05 | 3 | 82 | 2 | 20566830 | |
| Pubmed | Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus. | 1.64e-05 | 3 | 82 | 2 | 7884913 | |
| Pubmed | N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins. | 1.64e-05 | 3 | 82 | 2 | 25505062 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 31595054 | ||
| Pubmed | Role of APOBEC3 in genetic diversity among endogenous murine leukemia viruses. | 1.64e-05 | 3 | 82 | 2 | 17967065 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 20335265 | ||
| Pubmed | Deaminase-Dead Mouse APOBEC3 Is an In Vivo Retroviral Restriction Factor. | 1.64e-05 | 3 | 82 | 2 | 29593034 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 31830125 | ||
| Pubmed | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response. | 1.64e-05 | 3 | 82 | 2 | 21998583 | |
| Pubmed | Direct inhibition of human APOBEC3 deaminases by HIV-1 Vif independent of the proteolysis pathway. | 1.64e-05 | 3 | 82 | 2 | 38115583 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 38092725 | ||
| Pubmed | Genome-wide association study of kidney function decline in individuals of European descent. | 1.64e-05 | 3 | 82 | 2 | 25493955 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 2157836 | ||
| Pubmed | Distinctive High Expression of Antiretroviral APOBEC3 Protein in Mouse Germinal Center B Cells. | 1.64e-05 | 3 | 82 | 2 | 35458563 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 22275865 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 293683 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 19150103 | ||
| Pubmed | Initial sequencing and comparative analysis of the mouse genome. | 1.64e-05 | 3 | 82 | 2 | 12466850 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 22294749 | ||
| Pubmed | Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo. | 3.28e-05 | 4 | 82 | 2 | 18983852 | |
| Pubmed | APOBEC3 regulates keratinocyte differentiation and expression of Notch3. | 3.28e-05 | 4 | 82 | 2 | 31400166 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 19037107 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 23725696 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 21985787 | ||
| Pubmed | APOBEC3A functions as a restriction factor of human papillomavirus. | 3.28e-05 | 4 | 82 | 2 | 25355878 | |
| Pubmed | Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms. | 3.28e-05 | 4 | 82 | 2 | 26253512 | |
| Pubmed | Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. | 3.28e-05 | 4 | 82 | 2 | 17020885 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 20375169 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 21147467 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 16055735 | ||
| Pubmed | The incorporation of APOBEC3 proteins into murine leukemia viruses. | 3.28e-05 | 4 | 82 | 2 | 18572219 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 16378963 | ||
| Pubmed | Multifaceted HIV-1 Vif interactions with human E3 ubiquitin ligase and APOBEC3s. | 3.28e-05 | 4 | 82 | 2 | 32893454 | |
| Pubmed | Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. | 3.28e-05 | 4 | 82 | 2 | 15269786 | |
| Pubmed | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection. | 3.28e-05 | 4 | 82 | 2 | 24821801 | |
| Pubmed | Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. | 3.28e-05 | 4 | 82 | 2 | 20363737 | |
| Pubmed | Expression and subcellular localisation of AID and APOBEC3 in adenoid and palatine tonsils. | 3.28e-05 | 4 | 82 | 2 | 29343743 | |
| Pubmed | APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | 3.28e-05 | 4 | 82 | 2 | 15674295 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 21873525 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 25501566 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 18702815 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 20538015 | ||
| Pubmed | Deubiquitinase USP47-stabilized splicing factor IK regulates the splicing of ATM pre-mRNA. | 3.28e-05 | 4 | 82 | 2 | 32377397 | |
| Pubmed | The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. | 3.28e-05 | 4 | 82 | 2 | 38049664 | |
| Pubmed | Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection. | 3.28e-05 | 4 | 82 | 2 | 26846717 | |
| Pubmed | Vaccinia virus replication is not affected by APOBEC3 family members. | 3.28e-05 | 4 | 82 | 2 | 17052331 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 28415995 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 9223268 | ||
| Pubmed | Species-specific restriction of apobec3-mediated hypermutation. | 3.28e-05 | 4 | 82 | 2 | 18032489 | |
| Pubmed | Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. | 3.28e-05 | 4 | 82 | 2 | 25303118 | |
| Pubmed | APOBEC3 inhibits mouse mammary tumour virus replication in vivo. | 3.28e-05 | 4 | 82 | 2 | 17259974 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 23555255 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 36480186 | ||
| Pubmed | 5.41e-05 | 31 | 82 | 3 | 36445780 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 34137443 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 21659520 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 18577210 | ||
| Pubmed | Structural basis of amine odorant perception by a mammal olfactory receptor. | 5.47e-05 | 5 | 82 | 2 | 37225986 | |
| Pubmed | IFN-α and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways. | 5.47e-05 | 5 | 82 | 2 | 22972924 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 18304004 | ||
| Pubmed | Trace amines: identification of a family of mammalian G protein-coupled receptors. | 5.47e-05 | 5 | 82 | 2 | 11459929 | |
| Pubmed | APOBEC3 inhibits DEAD-END function to regulate microRNA activity. | 5.47e-05 | 5 | 82 | 2 | 23890083 | |
| Pubmed | Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo. | 5.47e-05 | 5 | 82 | 2 | 24851906 | |
| Pubmed | Multiple loci associated with indices of renal function and chronic kidney disease. | 5.47e-05 | 5 | 82 | 2 | 19430482 | |
| Cytoband | 8q24.12 | 2.43e-04 | 13 | 82 | 2 | 8q24.12 | |
| GeneFamily | Trace amine receptors | 3.23e-04 | 9 | 55 | 2 | 188 | |
| GeneFamily | Apolipoprotein B mRNA editing enzyme catalytic subunits | 5.88e-04 | 12 | 55 | 2 | 406 | |
| GeneFamily | Ubiquitin specific peptidases | 6.59e-04 | 56 | 55 | 3 | 366 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 6.94e-04 | 57 | 55 | 3 | 1179 | |
| GeneFamily | Potassium voltage-gated channels | 6.58e-03 | 40 | 55 | 2 | 274 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.82e-03 | 394 | 55 | 5 | 471 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 159 | 82 | 5 | 3bab00f8fb7d9232538e50f83dd0fd70ddd16819 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 160 | 82 | 5 | 5bec867def73fa8531f8dad611679f4b44f573bd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 161 | 82 | 5 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-05 | 164 | 82 | 5 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.32e-05 | 164 | 82 | 5 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.44e-05 | 167 | 82 | 5 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-4|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.75e-05 | 174 | 82 | 5 | 15e2b9f46404ff9575e149024b24cb17b50b02b5 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.90e-05 | 177 | 82 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 178 | 82 | 5 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 178 | 82 | 5 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 2.06e-05 | 180 | 82 | 5 | 806e2f6138b630b9d7c41df75ec208e0a2298ee0 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.41e-05 | 186 | 82 | 5 | 153c8b2fd8a6e2141ca97c626f82e5f081f3180a | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | 64dd28b23eda7dfb7fd069be2742de7bad0fd87a | |
| ToppCell | droplet-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 187 | 82 | 5 | b535d5447bf15e95dcf025a0a455628b956fc857 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.67e-05 | 190 | 82 | 5 | d072bb285bd34d518b958e7c9ad44739c60b359c | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 191 | 82 | 5 | 4bfdf44d4402a42530d30c89d94946acdda4321b | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.02e-05 | 195 | 82 | 5 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| Disease | remnant cholesterol measurement | 1.87e-04 | 108 | 77 | 4 | EFO_0010815 | |
| Disease | free cholesterol measurement | 2.22e-04 | 113 | 77 | 4 | EFO_0008591 | |
| Disease | corneodesmosin measurement | 2.39e-04 | 9 | 77 | 2 | EFO_0801499 | |
| Disease | CCL17 measurement | 2.39e-04 | 9 | 77 | 2 | EFO_0009414 | |
| Disease | phospholipids in medium LDL measurement | 2.89e-04 | 49 | 77 | 3 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 2.89e-04 | 49 | 77 | 3 | EFO_0022224 | |
| Disease | phospholipids in medium VLDL measurement | 3.44e-04 | 52 | 77 | 3 | EFO_0022154 | |
| Disease | total lipids in medium LDL | 3.44e-04 | 52 | 77 | 3 | EFO_0022180 | |
| Disease | total lipids in LDL measurement | 3.44e-04 | 52 | 77 | 3 | EFO_0022308 | |
| Disease | cholesterol in small VLDL measurement | 3.64e-04 | 53 | 77 | 3 | EFO_0022228 | |
| Disease | C-C motif chemokine 17 measurement | 4.36e-04 | 12 | 77 | 2 | EFO_0008045 | |
| Disease | phospholipids in small LDL measurement | 5.00e-04 | 59 | 77 | 3 | EFO_0022297 | |
| Disease | cholesteryl ester measurement | 5.71e-04 | 257 | 77 | 5 | EFO_0010351 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 6.95e-04 | 66 | 77 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | central nervous system disease (implicated_via_orthology) | 7.88e-04 | 16 | 77 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | household income | 1.21e-03 | 304 | 77 | 5 | EFO_0009695 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.53e-03 | 189 | 77 | 4 | EFO_0009932 | |
| Disease | open-angle glaucoma | 1.59e-03 | 191 | 77 | 4 | EFO_0004190 | |
| Disease | CCL11 measurement | 1.64e-03 | 23 | 77 | 2 | EFO_0005188 | |
| Disease | lipid measurement, lipoprotein measurement | 1.71e-03 | 90 | 77 | 3 | EFO_0004529, EFO_0004732 | |
| Disease | Malignant neoplasm of breast | 1.90e-03 | 1074 | 77 | 9 | C0006142 | |
| Disease | corpus callosum mid-anterior volume measurement | 2.26e-03 | 27 | 77 | 2 | EFO_0010297 | |
| Disease | corpus callosum volume measurement | 2.30e-03 | 100 | 77 | 3 | EFO_0010299 | |
| Disease | lumbar disc degeneration | 2.43e-03 | 28 | 77 | 2 | EFO_0004994 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 2.44e-03 | 102 | 77 | 3 | EFO_0004329, EFO_0004611 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.45e-03 | 215 | 77 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.60e-03 | 713 | 77 | 7 | EFO_0005689 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ACCAKYTSDDFWYRA | 996 | Q9BXT4 | |
| CNSDGEWVYNTFCIY | 96 | P04003 | |
| SCLFPACRDYWTYQG | 181 | P07451 | |
| YQSWDDFICYCELTG | 556 | P78357 | |
| TARLCYFWDTDYQEG | 316 | Q96AK3 | |
| FEYCWDTFVYRQGCP | 341 | Q9UH17 | |
| ERFNWHYCVLGCESF | 376 | O00481 | |
| CLAYGGSDVSRCFYW | 306 | Q9H981 | |
| CWDGYGEFSCTLTKY | 156 | Q8N139 | |
| SALCSLGYCVWYGSA | 126 | Q16570 | |
| VCDCSLYSLLVFWYR | 231 | Q86SJ2 | |
| DNYWFGRDKSCEYCF | 111 | O96017 | |
| SSSEYCVEKWCRDYF | 561 | Q7L7V1 | |
| YLCIFCYGIRFLWSS | 151 | Q8N5B7 | |
| YYYSWSFACACAAFI | 176 | Q06432 | |
| CWCLDEANYIYAGLA | 546 | Q6PCD5 | |
| RCFGCAVIEDTWHYF | 141 | Q15800 | |
| RLEWCSCYYHGNFSL | 1366 | O75140 | |
| GYSYILGWICFCFSF | 131 | P54849 | |
| YSCLCTLGWVGRYCE | 2956 | Q5T1H1 | |
| YRACKFAEWCLDYGA | 391 | Q9NS86 | |
| WNCFVFLYDTDRGYS | 151 | P48058 | |
| WYSGRSDAGCLYELT | 206 | Q9UK22 | |
| SFCVIYLNWIEYCSS | 1761 | Q96RV3 | |
| VRYFCYGCLFTSATW | 6 | Q8NCW6 | |
| EYWGINEFFIDSCCS | 106 | Q9ULS6 | |
| YCSTDLYSLWSAVGC | 186 | Q96LW2 | |
| DVSCSRSHAYYVCAW | 276 | Q96S97 | |
| GFASWIEYLCVDHCF | 376 | A6NEC2 | |
| WYYCSSCHVDDSFLI | 536 | Q6ZWE6 | |
| FASLCAWYSGYLLAE | 16 | P58499 | |
| INTTWCAGYCYTRDL | 41 | P01225 | |
| DGCTFYFLWESAEAC | 861 | A8MWY0 | |
| ERGSWSCELCYFKYQ | 146 | Q86YJ5 | |
| FSQSCVWYGECGIAY | 21 | O15118 | |
| RCLYYTSFSLELCWQ | 176 | Q5VTY9 | |
| YWGIDEIYLESCCQA | 121 | Q14721 | |
| SCGYDTCYDWEKCSA | 861 | P13671 | |
| FGCLSCRLFYYRLWD | 276 | Q49AN0 | |
| VTCLQYYCEYCWASI | 656 | Q8NE35 | |
| YYCEYCWASIHSRAG | 661 | Q8NE35 | |
| WGIGYSFRCDIVDYS | 91 | A1L3X0 | |
| DSDWTGYYCNCTTRT | 576 | P05106 | |
| AVYRCSASTRLWYEC | 691 | Q5VTJ3 | |
| AWTYTFYDNCCRLRC | 36 | Q08477 | |
| GEDFTCFWAGCVRRY | 226 | Q8NBF1 | |
| AYYLACGFCRWTSRD | 106 | Q9UJW0 | |
| GFASWIEYLCVDHCF | 376 | P55786 | |
| ASCWHEDSLFRFCYY | 161 | Q9UNU6 | |
| FPRALEECFFAYCWA | 691 | Q05469 | |
| WRSSTVCSLDCEYYN | 1196 | Q3ZCN5 | |
| CFYREDEWCAGFGLY | 1316 | Q9P2P1 | |
| FYVKGFYCAECRAGW | 106 | Q6UXH9 | |
| FYCAECRAGWYGGDC | 111 | Q6UXH9 | |
| YKCICSDGWEGAYCE | 651 | P78504 | |
| DTYSLYCYPCTWGDC | 546 | Q75VX8 | |
| DSCTYYFSWDSRAAC | 2111 | P11717 | |
| LEYVSSLDFWYCKRC | 531 | P78332 | |
| RCTFCVDAGVWYYEV | 351 | Q96DX4 | |
| EYSCAYDGCRQLIWY | 396 | Q96DX4 | |
| DILEDYCMWRGYEYC | 516 | P28370 | |
| VRTVESCWYFGRSFC | 91 | Q96RI8 | |
| VRSVESCWYFGDSYC | 91 | Q96RI9 | |
| EIYRFGTQYWFLGCC | 91 | Q9Y289 | |
| TRFWFPCVDSYSELC | 186 | Q6P1X5 | |
| CGNYTTFWGACFAYI | 141 | Q7Z3Q1 | |
| CHLWYAVLCGYVSEF | 261 | Q96LZ7 | |
| RDPYCAWDGSACSRY | 531 | Q14563 | |
| TSYYWCKFCSFSCES | 431 | Q9UHF7 | |
| FLYSFSWDFECSQCG | 351 | Q5W0Q7 | |
| EGYACDTDLRGWYRF | 191 | P07911 | |
| WIYCVGEDFVLYCFS | 456 | Q2TAY7 | |
| YCEPAFWCSISYYEL | 226 | P84022 | |
| YDSYAMYLCEWCRTR | 86 | Q8TBR7 | |
| YALNWLGSLFACYCS | 196 | Q9NUY8 | |
| ECTTYWYIFVFCSAL | 106 | Q6UX40 | |
| CLECGYEGWRIDTYL | 311 | Q96K76 | |
| VSECSYCGARWDQYK | 416 | Q5T7W7 | |
| YKGVYEGWYCASDEC | 161 | Q96GW9 | |
| YFCRYCAWRVFSDTA | 221 | Q96EH8 | |
| CVYCSYGSWDLFREA | 211 | Q969W1 | |
| RCCGVSNYTDWFEVY | 146 | O14817 | |
| AACYVCWAFARAYEP | 466 | Q9BTW9 | |
| AYCKNSVDGLWYCFD | 726 | Q70CQ4 | |
| WCRGYFRDYCNIIAF | 106 | P0DMS9 | |
| YDCAECGKSFSYWSS | 446 | Q99676 |